1
|
Bauer-Negrini G, Deckmann I, Schwingel GB, Hirsch MM, Fontes-Dutra M, Carello-Collar G, Halliwell DE, Paraskevaidi M, Morais CLM, Martin FL, Riesgo R, Gottfried C, Bambini-Junior V. The role of T-cells in neurobehavioural development: Insights from the immunodeficient nude mice. Behav Brain Res 2021; 418:113629. [PMID: 34656692 DOI: 10.1016/j.bbr.2021.113629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Revised: 09/20/2021] [Accepted: 10/09/2021] [Indexed: 11/02/2022]
Abstract
Mice homozygous for the nude mutation (Foxn1nu) are hairless and exhibit congenital dysgenesis of the thymic epithelium, resulting in a primary immunodeficiency of mature T-cells, and have been used for decades in research with tumour grafts. Early studies have already demonstrated social behaviour impairments and central nervous system (CNS) alterations in these animals, but did not address the complex interplay between CNS, immune system and behavioural alterations. Here we investigate the impact of T-cell immunodeficiency on behaviours relevant to the study of neurodevelopmental and neuropsychiatric disorders. Moreover, we aimed to characterise in a multidisciplinary manner the alterations related to those findings, through evaluation of the excitatory/inhibitory synaptic proteins, cytokines expression and biological spectrum signature of different biomolecules in nude mice CNS. We demonstrate that BALB/c nude mice display sociability impairments, a complex pattern of repetitive behaviours and higher sensitivity to thermal nociception. These animals also have a reduced IFN-γ gene expression in the prefrontal cortex and an absence of T-cells in meningeal tissue, both known modulators of social behaviour. Furthermore, excitatory synaptic protein PSD-95 immunoreactivity was also reduced in the prefrontal cortex, suggesting an intricate involvement of social behaviour related mechanisms. Lastly, employing biospectroscopy analysis, we have demonstrated that BALB/c nude mice have a different CNS spectrochemical signature compared to their heterozygous littermates. Altogether, our results show a comprehensive behavioural analysis of BALB/c nude mice and potential neuroimmunological influences involved with the observed alterations.
Collapse
Affiliation(s)
- Guilherme Bauer-Negrini
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365, Manguinhos, CEP: 21040-900, Rio de Janeiro, Brazil.
| | - Iohanna Deckmann
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365, Manguinhos, CEP: 21040-900, Rio de Janeiro, Brazil.
| | - Gustavo Brum Schwingel
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365, Manguinhos, CEP: 21040-900, Rio de Janeiro, Brazil.
| | - Mauro Mozael Hirsch
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365, Manguinhos, CEP: 21040-900, Rio de Janeiro, Brazil.
| | - Mellanie Fontes-Dutra
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365, Manguinhos, CEP: 21040-900, Rio de Janeiro, Brazil.
| | - Giovanna Carello-Collar
- Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil.
| | - Diane E Halliwell
- Alliance Manchester Business School, University of Manchester, Booth St W, M15 6PB, UK.
| | - Maria Paraskevaidi
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire. Marsh Ln, PR1 2HE. Preston, Lancashire, UK.
| | - Camilo L M Morais
- School of Pharmacy and Biomedical Sciences, University of Central Lancashire. Marsh Ln, PR1 2HE. Preston, Lancashire, UK.
| | - Francis L Martin
- Biocel UK Ltd., 15 Riplingham Road, West Ella, Hull, HU10 6TS, UK.
| | - Rudimar Riesgo
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Child Neurology Unit, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2350, Porto Alegre, CEP: 90035-007, Rio Grande do Sul, Brazil.
| | - Carmem Gottfried
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; Department of Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; National Institute of Science and Technology on Neuroimmunomodulation (INCT-NIM), Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365, Manguinhos, CEP: 21040-900, Rio de Janeiro, Brazil.
| | - Victorio Bambini-Junior
- Translational Research Group in Autism Spectrum Disorder (GETTEA), Universidade Federal do Rio Grande do Sul (UFRGS). Rua Ramiro Barcelos, 2600, CEP: 90035-003, Porto Alegre, Brazil; School of Pharmacy and Biomedical Sciences, University of Central Lancashire. Marsh Ln, PR1 2HE. Preston, Lancashire, UK.
| |
Collapse
|
2
|
Tremblay A, Lingrand L, Maillard M, Feuz B, Tompkins TA. The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2021; 105:110142. [PMID: 33069817 DOI: 10.1016/j.pnpbp.2020.110142] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Revised: 09/28/2020] [Accepted: 10/12/2020] [Indexed: 02/07/2023]
Abstract
Psychobiotics are considered among potential avenues for modulating the bidirectional communication between the gastrointestinal tract and central nervous system, defined as the microbiota-gut-brain axis (MGBA). Even though causality has not yet been established, intestinal dysbiosis has emerged as a hallmark of several diseases, including neuropsychiatric disorders (NPDs). The fact that the microbiota and central nervous system are co-developing during the first years of life has provided a paradigm suggesting a potential role of psychobiotics for earlier interventions. Studies in animal models of early-life stress (ELS) have shown that they can counteract the pervasive effects of stress during this crucial developmental period, and rescue behavioral symptoms related to anxiety and depression later in life. In humans, evidence from clinical studies on the efficacy of psychobiotics at improving mental outcomes in most NPDs remain limited, except for major depressive disorder for which more studies are available. Consequently, the beneficial effect of psychobiotics on depression-related outcomes in adults are becoming clearer. While the specific mechanisms at play remain elusive, the effect of psychobiotics are generally considered to involve the hypothalamic-pituitary-adrenal axis, intestinal permeability, and inflammation. It is anticipated that future clinical studies will explore the potential role of psychobiotics at mitigating the risk developing NPDs in vulnerable individuals or in the context of childhood adversity. However, such studies remain challenging at present in terms of design and target populations; the profound impact of stress on the proper development of the MGBA during the first year of life is becoming increasingly recognized, but the trajectories post-ELS in humans and the mechanisms by which stress affects the susceptibility to various NPDs are still ill-defined. As psychobiotics are likely to exert both shared and specific mechanisms, a better definition of target subpopulations would allow to tailor psychobiotics selection by aligning mechanistic properties with known pathophysiological mechanisms or risk factors. Here we review the available evidence from clinical and preclinical studies supporting a role for psychobiotics at ameliorating depression-related outcomes, highlighting the knowledge gaps and challenges associated with conducting longitudinal studies to address outstanding key questions in the field.
Collapse
Affiliation(s)
- Annie Tremblay
- Rosell® Institute for Microbiome and Probiotics, 6100 Royalmount Avenue, Montreal, Quebec H4P 2R2, Canada
| | - Lucie Lingrand
- Lallemand Health Solutions, 19 Rue des Briquetiers, 31702 Blagnac, France
| | - Morgane Maillard
- Lallemand Health Solutions, 19 Rue des Briquetiers, 31702 Blagnac, France
| | - Berengere Feuz
- Lallemand Health Solutions, 19 Rue des Briquetiers, 31702 Blagnac, France
| | - Thomas A Tompkins
- Rosell® Institute for Microbiome and Probiotics, 6100 Royalmount Avenue, Montreal, Quebec H4P 2R2, Canada.
| |
Collapse
|
3
|
Cushman J, Lo J, Huang Z, Wasserfall C, Petitto JM. Neurobehavioral changes resulting from recombinase activation gene 1 deletion. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 2003; 10:13-8. [PMID: 12522033 PMCID: PMC145286 DOI: 10.1128/cdli.10.1.13-18.2003] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Recombinase activation gene 1 (RAG-1) function is essential for V(D)J recombination in T-cell-receptor and immunoglobulin rearrangements whereby the immune system may encode memories of a vast array of antigens. The RAG-1 gene is also localized to neurons in the hippocampal formation and related limbic regions that are involved in spatial learning and memory as well as other parameters of neurobehavioral performance. Since the unique ability to encode memory is shared by the immune system and the brain, we tested the hypothesis that loss of the RAG-1 gene in the brain would influence learning and memory performance and examined several different domains of behavior in RAG-1-knockout and control mice. Compared to control mice, RAG-1-knockout mice exhibited increased locomotor activity in an open field under both dim and bright lighting conditions and decreased habituation (reduction in the expected decline in locomotor activity with increasing familiarity with the novel environment in a 1-h test session) in bright lighting. RAG-1-knockout mice also showed reduced levels of fearfulness for some measures of fear-motivated behavior in both the open-field behavior test and elevated-plus maze test. Contrary to our hypothesis, no differences in spatial learning and memory were found between the groups, although modest differences were observed visible-platform testing in the Morris water maze. Neither prepulse inhibition, a measure of sensorimotor gating, nor reflexive acoustic startle responses differed between the RAG-1-knockout and control mice. It remains to be determined if these changes are due to the loss of RAG-1 gene expression in the brain, are due to the absence of the gene in the immune system (e.g., the loss of cytokines with neuromodulatory activities), or are due to some combination of both effects. Study of the neurobiological actions of RAG-1 in the brain may provide new insights into important processes involved in normal brain function and disease.
Collapse
Affiliation(s)
- Jesse Cushman
- Department of Psychiatry, McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida 32610, USA
| | | | | | | | | |
Collapse
|